| Aug 12 |
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
|
| Aug 8 |
Oncternal Therapeutics (ONCT) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 6 |
Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
|
| Jul 17 |
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
|
| Jul 12 |
4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last?
|
| Jul 11 |
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
|
| Jun 11 |
Public companies are Journey Medical Corporation's (NASDAQ:DERM) biggest owners and were rewarded after market cap rose by US$26m last week
|
